# TARGETING DUAL PATHWAYS IN REFRACTORY COCCYDYNIA

> **NCT07060313** · PHASE3 · COMPLETED · sponsor: **Istanbul University** · enrollment: 60 (actual)

## Conditions studied

- Coccydynia

## Interventions

- **PROCEDURE:** Ganglion Impar Block
- **PROCEDURE:** Ganglion Impar Block and Pericoccygeal Injection

## Key facts

- **NCT ID:** NCT07060313
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060313, "TARGETING DUAL PATHWAYS IN REFRACTORY COCCYDYNIA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07060313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*